Liu Jialin,Liu Ying,Tang Liangfeng,et al.Evaluations of botulinum toxin injection into detrusor for neurogenic detrusor overactivity in children[J].Journal of Clinical Pediatric Surgery,2022,21(08):752-757.[doi:10.3760/cma.j.cn101785-202203025-009]
A型肉毒杆菌毒素膀胱注射治疗儿童神经源性膀胱逼尿肌过度活动的效果评价
- Title:
- Evaluations of botulinum toxin injection into detrusor for neurogenic detrusor overactivity in children
- Keywords:
- Urinary Bladder; Neurogenic/DT; Urinary Bladder; Neurogenic/SU; Botulinum Toxins; Type A; Treatment Outcome; Child
- 摘要:
- 目的 评价经膀胱镜A型肉毒杆菌毒素膀胱注射治疗儿童神经源性膀胱逼尿肌过度活动的临床效果。方法 收集2020年4月至2021年6月在复旦大学附属儿科医院行A型肉毒杆菌毒素膀胱注射治疗的神经源性膀胱患儿临床资料,进行自身前后对照分析。患儿在注射治疗前均已接受清洁间歇导尿、持续性预防性抗生素及抗胆碱药物治疗,但效果不理想。分别比较注射前及注射后1个月、3个月、6个月的清洁间歇导尿最大单次导尿量及发热性尿路感染发生率的变化;比较注射前、注射后3个月充盈期膀胱壁厚度以及膀胱最大灌注量、膀胱安全容量、膀胱顺应性变化;观察注射治疗后并发症情况。结果 共11例患儿纳入研究,其中男1例,女10例。注射治疗时年龄(80.36±43.35)个月,体重(21.86±7.47) kg。注射前导尿频率为(5.86±1.60)次/天,单次最大导尿量为(152.73±58.10) mL,发热性尿路感染发生率为100%,膀胱壁厚度为(4.41±1.95) mm,尿动力检查膀胱最大灌注量(158.44±57.26) mL,膀胱安全容量(139.78±66.09) mL,膀胱顺应性(4.37±2.16) mL/cmH2O。注射后1个月、3个月、6个月的导尿频率分别为(6.18±2.31)次/天(P=0.652)、(5.91±2.38)次/天(P=0.948)、(5.68±1.91)次/天(P=0.736)。注射后1个月、3个月、6个月最大单次导尿量分别增加至(206.82±72.05) mL (P=0.004)、(227.28±94.67) mL (P=0.003)、(185.46±75.38) mL (P=0.024)。发热性尿路感染发生率注射后1个月、3个月均为9%(P<0.001),注射后6个月为27%(P=0.001)。注射后3个月膀胱壁厚度(2.75±0.84) mm,较术前显著改善(P=0.004);尿动力检查膀胱最大灌注量(225.44±94.03) mL (P=0.041)、膀胱安全容量(216.11±106.44) mL (P=0.049)、膀胱顺应性(9.43±5.74) mL/cmH2O (P=0.023),均较术前明显改善。随访周期内11例均未观察到与注射治疗相关的并发症。结论 经膀胱镜A型肉毒杆菌毒素膀胱注射对增加神经源性膀胱患儿膀胱功能性容量、降低膀胱压力、防治尿路感染有一定作用,可为对口服抗胆碱药物不耐受的患儿提供潜在选择。
- Abstract:
- Objective To evaluate the clinical efficacy of botulinum toxin injection for pediatric neurogenic detrusor overactivity.Methods From April 2020 to June 2021,a retrospective observational self-control study was performed for neurogenic detrusor overactive children receiving an injection of botulinum toxin at Department of Pediatric Urological Surgery of Children’s Hospital of Fudan University.All cases received continuous antibiotic prophylaxis with limited effect.Febrile urinary tract infection,maximal voiding volume at Month 1/3/6 post-injection,bladder wall thickness on ultrasound,maximal bladder capacity,safe bladder capacity and bladder urodynamic compliance at Month 3 post-injection were compared before and after injection.Results There were 1 boy and 10 girls with a mean age of (80.36±43.35) months and a mean weight of (21.86±7.47) kg.Prior to injection,mean clean intermittent catheterization frequency was (5.86±1.60) times per day,maximal bladder capacity (152.73±58.10) mL,rate of febrile urinary tract infection 100% and bladder wall thickness (4.41±1.95) mm.In pre-injection urodynamic tests,maximal bladder capacity was (158.44±57.26) mL,safe bladder capacity (139.78±66.09) mL and bladder compliance (4.37±2.16) mL/cmH2O.After injection,mean clean intermittent catheterization frequency at Month 1 was (6.18±2.31) times per day (P=0.652),Month 3(5.91±2.38) times per day (P=0.948),Month 6(5.68±1.91) times per day (P=0.736),maximal voiding volume at Month 1(206.82±72.05) mL (P=0.004),Month 3(227.28±94.67) mL (P=0.003) and Month 6(227.28±94.67) mL (P=0.024).Febrile urinary tract infection rate at Month 1 was 1(9%)(P<0.001),Month 3 1(9%)(P<0.001) and Month 6 3(27%)(P=0.001).There were marked improvements.And at Month 3,bladder wall thickness was (2.75±0.84) mm (P=0.004),maximal bladder capacity (225.44±94.03) mL (P=0.041),safe bladder capacity (216.11±106.44) mL (P=0.049) and bladder compliance (9.43±5.74) mL/cmH2O (P=0.023).There were marked improvements.No severe side effects were recorded.Conclusion An injection of botulinum toxin has marked effects upon bladder capacity and pressure in bladder and helps reduce febrile urinary infection in neurogenic bladder children.And botulinum toxin injection is indicated for individuals not tolerating anticholinergic agents.
参考文献/References:
[1] Sripathi V,Mitra A.Management of neurogenic bladder[J].Indian J Pediatr,2017,84(7):545-554.DOI:10.1007/s12098-017-2356-7.
[2] Stein R,Bogaert G,Dogan HS,et al.EAU/ESPU guidelines on the management of neurogenic bladder in children and adolescent part II operative management[J].Neurourol Urodyn,2020,39(2):498-506.DOI:10.1002/nau.24248.
[3] Cooley LF,Kielb S.A review of botulinum toxin a for the treatment of neurogenic bladder[J].PM R,2019,11(2):192-200.DOI:10.1016/j.pmrj.2018.07.016.
[4] Baldwin MR,Barbieri JT.Association of botulinum neurotoxins with synaptic vesicle protein complexes[J].Toxicon,2009,54(5):570-574.DOI:10.1016/j.toxicon.2009.01.040.
[5] Lightner DJ,Gomelsky A,Souter L,et al.Diagnosis and treatment of overactive bladder (Non-Neurogenic) in adults:AUA/SUFU guideline amendment 2019[J].J Urol,2019,202(3):558-563.DOI:10.1097/JU.0000000000000309.
[6] Sch?fer W,Abrams P,Liao L,et al.Good urodynamic practices:uroflowmetry,filling cystometry,and pressure-flow studies[J].Neurourol Urodyn,2002,21(3):261-274.DOI:10.1002/nau.10066.
[7] Dykstra DD,Sidi AA,Scott AB,et al.Effects of botulinum A toxin on detrusor-sphincter dyssynergia in spinal cord injury patients[J].J Urol,1988,139(5):919-922.DOI:10.1016/s0022-5347(17)42717-0.
[8] Reitz A,St?hrer M,Kramer G,et al.European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivity[J].Eur Urol,2004,45(4):510-515.DOI:10.1016/j.eururo.2003.12.004.
[9] Dyer LL,Franco I.Botulinum Toxin-A therapy in pediatric urology:indications for the neurogenic and non-neurogenic neurogenic bladder[J].Scientific World Journal,2009,9:1300-1305.DOI:10.1100/tsw.2009.146.
[10] Thaker H,Zhang S,Diamond DA,et al.Beyond botulinum neurotoxin A for chemodenervation of the bladder[J].Curr Opin Urol,2021,31(2):140-146.DOI:10.1097/MOU.0000000000000843.
[11] Hascoet J,Manunta A,Brochard C,et al.Outcomes of intra-detrusor injections of botulinum toxin in patients with spina bifida:A systematic review[J].Neurourol Urodyn,2017,36(3):557-564.DOI:10.1002/nau.23025.
[12] Kaviani A,Khavari R.Disease-specific outcomes of botulinum toxin injections for neurogenic detrusor overactivity[J].Urol Clin North Am,2017,44(3):463-474.DOI:10.1016/j.ucl.2017.04.012.
[13] Rovner E,Dmochowski R,Chapple C,et al.OnabotulinumtoxinA improves urodynamic outcomes in patients with neurogenic detrusor overactivity[J].Neurourol Urodyn,2013,32(8):1109-1115.DOI:10.1002/nau.22376.
[14] ?ekerci?A,I?bilen B,I?man F,et al.Urinary NGF,TGF-β1,TIMP-2 and bladder wall thickness predict neurourological findings in children with myelodysplasia[J].J Urol,2014,191(1):199-205.DOI:10.1016/j.juro.2013.08.025.
[15] Apostolidis A,Dasgupta P,Denys P,et al.Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions:a European consensus report[J].Eur Urol,2009,55(1):100-119.DOI:10.1016/j.eururo.2008.09.009.
[16] Rajkumar GN,Small DR,Mustafa AW,et al.A prospective study to evaluate the safety,tolerability,efficacy and durability of response of intravesical injection of botulinum toxin type A into detrusor muscle in patients with refractory idiopathic detrusor overactivity[J].BJU Int,2005,96(6):848-852.DOI:10.1111/j.1464-410X.2005.05725.x.
[17] 周广伦,孙俊杰,尹鉴淳,等.儿童神经源性膀胱并尿路感染的临床特点及病原菌分析[J].临床小儿外科杂志,2021,20(11):1021-1025.DOI:10.12260/lcxewkzz.2021.11.005. Zhou GL,Sun JJ,Yin JC,et al.Analysis of pathogens and clinical features of neuropathic bladder with urinary tract infection in children[J].J Clin Ped Sur,2021,20(11):1021-1025.DOI:10.12260/lcxewkzz.2021.11.005.
[18] Vigil HR,Hickling DR.Urinary tract infection in the neurogenic bladder[J].Transl Androl Urol,2016,5(1):72-87.DOI:10.3978/j.issn.2223-4683.2016.01.06.
[19] Wu CQ,Franco I.Management of vesicoureteral reflux in neurogenic bladder[J].Investig Clin Urol,2017,58(Suppl 1):S54-S58.DOI:10.4111/icu.2017.58.S1.S54.
相似文献/References:
[1]鲁中原 张建 张潍平 冀圆琦 李明磊 屈彦超. 脊髓脊膜膨出患儿尿动力学改变与上尿路损害的关系探讨[J].临床小儿外科杂志,2011,10(06):420.
[J].Journal of Clinical Pediatric Surgery,2011,10(08):420.
[2]李守林 刘晓东 姜俊海. 血浆和尿中内皮素、一氧化氮在神经源性膀胱中的检测及意义[J].临床小儿外科杂志,2014,13(06):488.
[3]张旭辉,罗添华,王计文,等.UPJO手术中双J管置入膀胱失败的危险因素分析[J].临床小儿外科杂志,2020,19(03):224.[doi:10.3969/j.issn.1671-6353.2020.03.007]
Zhang Xuhui,Luo Tianhua,Wang Jiwen,et al.Analysis of risk factors for failure of double J inserting into bladder during operation of ureteropelvic junction obstruction[J].Journal of Clinical Pediatric Surgery,2020,19(08):224.[doi:10.3969/j.issn.1671-6353.2020.03.007]
[4]於明明,陈方.组织工程技术在儿童下尿路重建修复中的若干问题[J].临床小儿外科杂志,2020,19(04):285.[doi:10.3969/j.issn.1671-6353.2020.04.001]
Yu Mingming,Chen Fang.Research progress of tissue engineering in pediatric urology[J].Journal of Clinical Pediatric Surgery,2020,19(08):285.[doi:10.3969/j.issn.1671-6353.2020.04.001]
[5]呼和,蒋飞,姬广春,等.光修复对脊髓栓系伴神经源性膀胱大鼠的作用研究[J].临床小儿外科杂志,2020,19(07):648.[doi:10.3969/j.issn.1671-6353.2020.07.017]
Hu He,Jiang Fei,Ji Guangchun,et al.Effect of light repair on spinal cord tether with neurogenic bladder in rats[J].Journal of Clinical Pediatric Surgery,2020,19(08):648.[doi:10.3969/j.issn.1671-6353.2020.07.017]
[6]杨丹,李明磊,谢向辉,等.盆底肌电图滞后时间诊断儿童特发性逼尿肌过度活跃的初步评价[J].临床小儿外科杂志,2020,19(11):981.[doi:10.3969/j.issn.1671-6353.2020.11.004]
Yang Dan,Li Minglei,Xie Xianghui,et al.A preliminary evaluation of pelvic floor electromyography lag time in the diagnosis of idiopathic detrusor overactivity disorder in children[J].Journal of Clinical Pediatric Surgery,2020,19(08):981.[doi:10.3969/j.issn.1671-6353.2020.11.004]
[7]李琦,蔡淼,吴盛德,等.神经源性膀胱上尿路损害的危险因素分析[J].临床小儿外科杂志,2022,21(03):253.[doi:10.3760/cma.j.cn101785-202108049-010]
Li Qi,Cai Miao,Wu Shengde,et al.Analysis of risk factors for upper urinary tract injury in children with neurogenic bladder[J].Journal of Clinical Pediatric Surgery,2022,21(08):253.[doi:10.3760/cma.j.cn101785-202108049-010]
[8]徐哲明,唐达星.儿童神经源性膀胱继发膀胱输尿管反流的临床治疗策略[J].临床小儿外科杂志,2022,21(09):881.[doi:10.3760/cma.j.cn101785-202111029-016]
Xu Zheming,Tang Daxing.Clinical treatment strategies of vesicoureteral reflux secondary to neurogenic bladder in children[J].Journal of Clinical Pediatric Surgery,2022,21(08):881.[doi:10.3760/cma.j.cn101785-202111029-016]
[9]左金明,王庆伟,朱文,等.逼尿肌及尿道外括约肌A型肉毒毒素注射治疗儿童逼尿肌过度活动并收缩受损的疗效与安全性分析[J].临床小儿外科杂志,2024,(04):348.[doi:10.3760/cma.j.cn101785-202403060-009]
Zuo Jinming,Wang Qingwei,Zhu Wen,et al.Efficacy and safety of detrusor and external urethral sphincter injections of botulinum toxin A in children with detrusor overactivity and impaired contractility[J].Journal of Clinical Pediatric Surgery,2024,(08):348.[doi:10.3760/cma.j.cn101785-202403060-009]
备注/Memo
收稿日期:2022-3-10。
基金项目:复旦大学附属儿科医院专病队列项目(2020ZBDL11)神经源性膀胱专病队列
通讯作者:王翔,Email:13501838663@163.com